1h Free Analyst Time
Global Chemiluminescence Analyzer Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the chemiluminescence analyzer market and it is poised to grow by $ 5.31 bn during 2021-2025 progressing at a CAGR of 9% during the forecast period. The report on chemiluminescence analyzer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing geriatric population, predictive and preventive medicine for early diagnosis and treatment and higher sensitivity and accuracy of CLIA over ELISA. In addition, increasing geriatric population is anticipated to boost the growth of the market as well.
The chemiluminescence analyzer market analysis includes product segment, end-user segment and geographical landscapes.
The chemiluminescence analyzer market is segmented as below:
By Product
- Benchtop CLA
- Floor-standing CLA
By End-user
- Hospitals and diagnostic centers
- Research laboratories
- Pharma and biotech companies
- Academic research centers
By Geographical Landscapes
- Europe
- North America
- APAC
- ROW
This study identifies the emergence of new disease targets as one of the prime reasons driving the chemiluminescence analyzer market growth during the next few years. Also, increasing growth potential in emerging economies and adoption of standardization and automation across the in vitro diagnostics industry will lead to sizable demand in the market.
The report on chemiluminescence analyzer market covers the following areas:
- Chemiluminescence analyzer market sizing
- Chemiluminescence analyzer market forecast
- Chemiluminescence analyzer market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chemiluminescence analyzer market vendors that include Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, Sysmex Corp., The Carlyle Group Inc., and Tosoh Corp.. Also, the chemiluminescence analyzer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by End-user
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global chemiluminescence analyzer (CLA) market: Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, Sysmex Corp., The Carlyle Group Inc., and Tosoh Corp..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is emergence of new disease targets.'
According to the report, one of the major drivers for this market is the increasing geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- bioMerieux SA
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Siemens Healthineers AG
- Sysmex Corp.
- The Carlyle Group Inc.
- Tosoh Corp.